Natixis’s Change Healthcare Inc. Common Stock CHNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,095,400
Closed -$113M 1424
2022
Q3
$113M Buy
4,095,400
+2,418,104
+144% +$59.9M 0.53% 29
2022
Q2
$38.7M Buy
1,677,296
+561,696
+50% +$13.1M 0.14% 92
2022
Q1
$24.3M Buy
1,115,600
+185,798
+20% +$3.86M 0.08% 226
2021
Q4
$19.9M Sell
929,802
-59,054
-6% -$1.24M 0.07% 242
2021
Q3
$20.7M Sell
988,856
-403,395
-29% -$8.8M 0.07% 232
2021
Q2
$32.1M Sell
1,392,251
-1,629,541
-54% -$37.5M 0.14% 145
2021
Q1
$66.8M Buy
+3,021,792
New +$69.9M 0.22% 100

Other funds holding CHNG

Natixis's CHNG Position: Q4 2022 in Review

Natixis sold out of Change Healthcare Inc. Common Stock (CHNG) in Q4 2022, closing a stake of 4,095,400 shares — an estimated $113M sold.

Natixis first reported a position in CHNG in Q1 2021 and held it in 7 quarters. The position peaked at $113M in Q3 2022. 1 fund tracked by Wall St. Rank holds CHNG as of Q4 2022.

  • Natixis reported no remaining Change Healthcare Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Natixis sold 4,095,400 Change Healthcare Inc. Common Stock shares in Q4 2022, an estimated $113M.
  • Natixis first reported a position in Change Healthcare Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Natixis's Change Healthcare Inc. Common Stock position peaked at $113M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Change Healthcare Inc. Common Stock as of Q4 2022.

Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.